Literature DB >> 24654972

Individually differentiated serotonergic raphe nuclei measured with brain PET/MR imaging.

Young-Don Son1, Zang-Hee Cho, Eun-Jung Choi, Jeong-Hee Kim, Hang-Keun Kim, Sang-Yoon Lee, Je-Geun Chi, Chan-Woong Park, Jong-Hoon Kim, Young-Bo Kim.   

Abstract

PURPOSE: To measure the activity of individual raphe nuclei with fluorine 18 fluorodeoxyglucose (FDG) and carbon 11 ((11)C) 3-amino-4-(2-dimethylaminomethylphenylthio) benzonitrile (DASB) imaging using a brain positron emission tomography(PET)/magnetic resonance (MR) imaging fusion system.
MATERIALS AND METHODS: The study was approved by the Institutional Review Board of Gil Medical Center, and all volunteers provided written informed consent. FDG PET, (11)C-DASB PET, and T2*-weighted MR images from seven healthy volunteers were acquired by using a PET/MR imaging fusion system. The standard uptake value ratio (SUVR) of FDG (FDG-SUVR) and nondisplaceable binding potential (BPnd) of (11)C-DASB (DASB-BPnd) were determined for each raphe nucleus. A Pearson correlation analysis was performed to show the correlation between FDG-SUVR and DASB-BPnd for the raphe nuclei.
RESULTS: Each raphe nucleus could be distinguished in both FDG (identifiability ratio, 0.86; κ = 0.77) and (11)C-DASB (identifiability ratio, 0.89; κ = 0.72) images. The mean values of DASB-BPnd for each raphe nucleus from dorsal to caudal direction were 6.08 (raphe nucleus 1), 5.93 (raphe nucleus 2), 3.86 (raphe nucleus 3), 3.18 (raphe nucleus 4), and 2.74 (raphe nucleus 5); the mean FDG-SUVR values were 1.00 (raphe nucleus 1), 1.00 (raphe nucleus 2), 0.87 (raphe nucleus 3), 0.94 (raphe nucleus 4), and 0.90 (raphe nucleus 5). FDG-SUVR and DASB-BPnd for the raphe nuclei were significantly correlated (r = 0.506, P = .002).
CONCLUSION: Serotonergic activity, both glucose metabolism and transporter binding potential of raphe nuclei, were measured with a brain-dedicated PET/MR imaging system and showed a significant correlation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24654972     DOI: 10.1148/radiol.14131547

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Will imaging individual raphe nuclei in males with major depressive disorder enhance diagnostic sensitivity and specificity?

Authors:  Rajapillai L I Pillai; Mengru Zhang; Jie Yang; Maura Boldrini; J John Mann; Maria A Oquendo; Ramin V Parsey; Christine DeLorenzo
Journal:  Depress Anxiety       Date:  2018-01-24       Impact factor: 6.505

Review 2.  Top-Down Control of Serotonin Systems by the Prefrontal Cortex: A Path toward Restored Socioemotional Function in Depression.

Authors:  Collin Challis; Olivier Berton
Journal:  ACS Chem Neurosci       Date:  2015-03-17       Impact factor: 4.418

Review 3.  Challenges and opportunities for brainstem neuroimaging with ultrahigh field MRI.

Authors:  Roberta Sclocco; Florian Beissner; Marta Bianciardi; Jonathan R Polimeni; Vitaly Napadow
Journal:  Neuroimage       Date:  2017-02-21       Impact factor: 6.556

4.  Resting state connectivity of the human habenula at ultra-high field.

Authors:  Salvatore Torrisi; Camilla L Nord; Nicholas L Balderston; Jonathan P Roiser; Christian Grillon; Monique Ernst
Journal:  Neuroimage       Date:  2016-10-22       Impact factor: 6.556

5.  Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [11C]DASB.

Authors:  Jeong-Hee Kim; Young-Don Son; Hang-Keun Kim; Jong-Hoon Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2021-10-21       Impact factor: 2.570

Review 6.  In vivo Brainstem Imaging in Alzheimer's Disease: Potential for Biomarker Development.

Authors:  David J Braun; Linda J Van Eldik
Journal:  Front Aging Neurosci       Date:  2018-09-11       Impact factor: 5.750

7.  Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging.

Authors:  David Matuskey; Sule Tinaz; Kyle C Wilcox; Mika Naganawa; Takuya Toyonaga; Mark Dias; Shannan Henry; Brian Pittman; Jim Ropchan; Nabeel Nabulsi; Ivonne Suridjan; Robert A Comley; Yiyun Huang; Sjoerd J Finnema; Richard E Carson
Journal:  Ann Neurol       Date:  2020-02-05       Impact factor: 10.422

8.  Comparative test-retest variability of outcome parameters derived from brain [18F]FDG PET studies in non-human primates.

Authors:  Sébastien Goutal; Nicolas Tournier; Martine Guillermier; Nadja Van Camp; Olivier Barret; Mylène Gaudin; Michel Bottlaender; Philippe Hantraye; Sonia Lavisse
Journal:  PLoS One       Date:  2020-10-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.